Agios Pharma (AGIO) Misses Q4 EPS by 7c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.74), $0.07 worse than the analyst estimate of ($1.67).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Agios Pharma (AGIO) PT Raised to $54 at H.C. Wainwright
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)